Your Gut Knows by SANNO

Innovating Research: Decentralised Clinical Trials

December 06, 2023 Ariadna Masó, SANNO CEO Season 3 Episode 2
Innovating Research: Decentralised Clinical Trials
Your Gut Knows by SANNO
More Info
Your Gut Knows by SANNO
Innovating Research: Decentralised Clinical Trials
Dec 06, 2023 Season 3 Episode 2
Ariadna Masó, SANNO CEO

Welcome to Episode 2 (S3): Innovating Research: Decentralised Clinical Trials

In a world where technology is reshaping our daily lives, it's also transforming the landscape of clinical research. Decentralised Clinical Trials (DCT) are at the forefront, moving activities beyond the hospital walls.

DCT holds the promise of accelerating research timelines, slashing costs, and improving patient recruitment—arguably one of the toughest aspects of clinical trials.

Yet, with every promise comes challenges. How does the pharmaceutical industry perceive this shift? What's the stance on integrating technology, and what hurdles exist in tech education and adoption?

In this episode, we're privileged to engage in a conversation with a seasoned professional in the pharmaceutical field: Angela May, Head DCT Strategy & Implementation, Clinical Operations at Bayer.

Here's a sneak peek at what we'll delve into:

  • What exactly are Decentralised Clinical Trials?
  • Exploring the pros and cons.
  • Unveiling the patient-centric benefits of DCTs.
  • Navigating the primary challenges.
  • A glimpse into the future: How will clinical trials be conducted in 5 years?

Join us for this insightful dialogue hosted by Ariadna Masó, founder and CEO of SANNO.

As Angela wisely puts it, Decentralised Clinical Trials are all about flexibility and understanding patient needs by directly asking them.

Don't miss out — subscribe to our podcast. It's the only request we'll ever make!

Let’s go!

For any feedback or enquiries, please get in touch at hello@sanno.health

Follow us on instagram at sanno.health
Tweet us at @sanno_health

See you on the Sanno app! Free download here: iOS/ Android

Show Notes

Welcome to Episode 2 (S3): Innovating Research: Decentralised Clinical Trials

In a world where technology is reshaping our daily lives, it's also transforming the landscape of clinical research. Decentralised Clinical Trials (DCT) are at the forefront, moving activities beyond the hospital walls.

DCT holds the promise of accelerating research timelines, slashing costs, and improving patient recruitment—arguably one of the toughest aspects of clinical trials.

Yet, with every promise comes challenges. How does the pharmaceutical industry perceive this shift? What's the stance on integrating technology, and what hurdles exist in tech education and adoption?

In this episode, we're privileged to engage in a conversation with a seasoned professional in the pharmaceutical field: Angela May, Head DCT Strategy & Implementation, Clinical Operations at Bayer.

Here's a sneak peek at what we'll delve into:

  • What exactly are Decentralised Clinical Trials?
  • Exploring the pros and cons.
  • Unveiling the patient-centric benefits of DCTs.
  • Navigating the primary challenges.
  • A glimpse into the future: How will clinical trials be conducted in 5 years?

Join us for this insightful dialogue hosted by Ariadna Masó, founder and CEO of SANNO.

As Angela wisely puts it, Decentralised Clinical Trials are all about flexibility and understanding patient needs by directly asking them.

Don't miss out — subscribe to our podcast. It's the only request we'll ever make!

Let’s go!

For any feedback or enquiries, please get in touch at hello@sanno.health

Follow us on instagram at sanno.health
Tweet us at @sanno_health

See you on the Sanno app! Free download here: iOS/ Android